Molecular Brake on Human Cell Division Prevents Cancer
One of biology’s great mysteries is how a single fertilised egg can generate millions of cells that together make up a human body, while simultaneously restricting growth to prevent lethal diseases such as cancer. This process is strictly regulated by our DNA, the genetic cookbook carried by each single cell in our body. Before a cell divides and generates two new daughter cells, it has to copy its DNA. How cells decide when to divide is a long-standing question in science.
Now, an international collaboration between Karolinska Institutet, Sweden, and the University of Sussex, England, led to the discovery of a built-in molecular brake on human cell division. The researchers revealed that the process of copying DNA generates a brake signal that stalls cell proliferation. This mechanism ensures that the cell has two complete copies of DNA before it divides and that all cells in a human contain similar genomes.
“By creating cells that cannot copy their DNA and by following protein activities over time in single cells, we found that DNA replication blocks the enzymes that trigger cell division. Immediately after DNA replication is completed, the machinery that starts cell division is activated. This fundamental mechanism contributes to determining when human cells will divide,” says Arne Lindqvist, senior researcher at the Department of Cell and Molecular Biology at Karolinska Institutet who led the study.
The researchers also show that the molecular brake ensures that the amount of DNA damage is minimised. When the brake is not functional, the cell divides before it is ready resulting in large amounts of DNA damage.
Provides important clues
“Our study highlights the dangerous consequences of hasty cell division and provides important clues on how cells might gain DNA mutations that ultimately give rise to cancer,” says lead author Bennie Lemmens, postdoctoral researcher at the Department of Medical Biochemistry and Biophysics at Karolinska Institutet.
The research was supported by the Wenner-Gren Foundation, the Swedish Research Council and the Swedish Cancer Society, among others.
This article has been republished from materials provided by Karolinska Institutet. Note: material may have been edited for length and content. For further information, please contact the cited source.
Lemmens, B., Hegarat, N., Akopyan, K., Sala-Gaston, J., Bartek, J., Hochegger, H., & Lindqvist, A. (2018). DNA Replication Determines Timing of Mitosis by Restricting CDK1 and PLK1 Activation. Molecular Cell. doi: 10.1016/j.molcel.2018.05.026
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.